Journal Articles

New technologies in V.A.C.® GranuFoam Bridge™ dressing

Share this article

New technologies in V.A.C.® GranuFoam Bridge™ dressing

Frank Bowling, Kath Crawford
31 May 2010

Foot ulceration is a serious complication of diabetes, with a reported incidence of 1–3.6% and a prevalence of up to 25% (Singh et al, 2005). The impact can be devastating and results in more hospital admissions than any other diabetes-related complication. It is the major contributing factor to lower extremity amputations (Pecoraro et al, 1990). Infection of diabetic foot wounds is a common and serious complication, which, if not managed effectively and quickly, can lead to extensive tissue destruction. Deep tissue samples are preferred, as they not only isolate surface dressingbacteria but also bacteria in the deeper tissues, and repeated sampling is important to verify isolates and target antimicrobial therapy. However, to avoid overuse of antimicrobial agents it is important to clinically differentiate between soft tissue infection and colonisation, although in patients with diabetes this can be extremely difficult due to dampened inflammatory responses.

Free for all healthcare professionals

Sign up to the Wounds Group journals

By clicking ‘Subscribe’, you are agreeing that the Wounds Group are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our privacy policy.

Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.

We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.

I am not a healthcare professional.